Profit Or Loss [Abstract]

HEMOGENYX PHARMACEUTICALS PLC - Filing #5969073

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	- GBP	—	—	—	—	—	—	—	—	- GBP	—	—	—	—	—	—
Administrative expenses	—	—	4,737,802 GBP	—	—	—	—	—	—	—	—	5,820,165 GBP	—	—	—	—	—	—
Profit (loss) from operating activities	—	—	5,377,087 GBP	—	—	—	—	—	—	—	—	6,465,846 GBP	—	—	—	—	—	—
Finance income	—	—	23,164 GBP	—	—	—	—	—	—	—	—	85,344 GBP	—	—	—	—	—	—
Finance costs	—	—	271,555 GBP	—	—	—	—	—	—	—	—	315,991 GBP	—	—	—	—	—	—
Profit (loss) before tax	—	—	5,625,478 GBP	—	—	—	—	—	—	—	—	6,696,493 GBP	—	—	—	—	—	—
Tax expense (income)	—	—	- GBP	—	—	—	—	—	—	—	—	- GBP	—	—	—	—	—	—
Profit (loss)	6,297 GBP	- GBP	5,625,478 GBP	- GBP	- GBP	- GBP	- GBP	- GBP	5,619,181 GBP	- GBP	- GBP	6,696,493 GBP	5,815 GBP	- GBP	6,690,678 GBP	- GBP	- GBP	- GBP
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent	—	—	5,619,181 GBP	—	—	—	—	—	—	—	—	6,690,678 GBP	—	—	—	—	—	—
Profit (loss), attributable to non-controlling interests	—	—	6,297 GBP	—	—	—	—	—	—	—	—	5,815 GBP	—	—	—	—	—	—